BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Drug Development

  NeuralStem Inc. Announces First Subject Dosed in NSI-189 Safety Testing Toward Major Depressive Disorder Trial

  March 1, 2011

   · 

  5 min read
• Drug Development

  Positive Pre-Clinical Data From Muscle Injury Study Moves Pluristem Therapeutics Toward Second Multi-Billion Dollar Clinical Indication

  March 1, 2011

   · 

  1 min read
• Drug Development

  NPS Pharmaceuticals, Inc. Completes Patient Randomization in Phase 3 Study of NPSP558 in Hypoparathyroidism

  March 1, 2011

   · 

  1 min read
• Business

  QLT Inc. Announces Fourth Quarter and Year End 2010 Results

  March 1, 2011

   · 

  1 min read
• Policy

  Align Technology, Inc. Files Lawsuits Against ClearCorrect

  March 1, 2011

   · 

  1 min read
• Drug Development

  Cytheris SA Announces Results of Phase IIa Study Indicating that Recombinant Interleukin-7 (CYT107) Expands CD4 T-Cells in Gut Mucosa of Chronically HIV Infected Immunological Non-Responder Patients

  March 1, 2011

   · 

  1 min read
• Pharm Country

  Mylan Inc. Confirms First-to-File Patent Challenge Relating to Vivelle-Dot(R)

  March 1, 2011

   · 

  2 min read
• BioForest

  ProtoKinetix Inc. Funds Independent Confirmatory Trials

  March 1, 2011

   · 

  1 min read
• Bohai Pharmaceuticals Group, Inc. to Present at Rodman & Renshaww Annual China Investment Conference

  March 1, 2011

   · 

  3 min read
• GTx, Inc. Announces Webcast of Corporate Presentation at the Cowen and Company Annual Health Care Conference

  March 1, 2011

   · 

  1 min read